Brief: HBM Healthcare Investments: Gilead Sciences To Acquire HBM Portfolio Company Immunomedics
Sept 14 (Reuters) - HBM Healthcare Investments AG HBMN.S :
* GILEAD SCIENCES TO ACQUIRE HBM PORTFOLIO COMPANY
IMMUNOMEDICS
* GILEAD WILL ACQUIRE IMMUNOMEDICS FOR USD 88.00 PER SHARE
IN
CASH.
* ANTICIPATED TO CLOSE DURING Q4 OF 2020
Source text for Eikon: ID:nTEN8cd9ba
Further company coverage: HBMN.S
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))
Recent news on HBM Healthcare Investments AG
See all newsSwiss stocks - Factors to watch on October 23
Brief: HBM Healthcare Investments Reports Q1 Profit CHF 238 Million
Brief: HBM Healthcare Investments Posts Profit Of CHF 272 Million
Brief: SK Capital Is Said To Near Deal For Swiss Drug Distributor Swixx That Could Value Co At About 1.5 Billion Euros- Bloomberg News
Brief: Mirum Pharmaceuticals To Acquire HBM Portfolio Company Bluejay Therapeutics